Puma Biotechnology, Inc. (PBYI) stock
PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)
Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –
Puma Biotechnology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Puma Biotechnology's market cap was $412.91M on Nov 11, 2026, against $254.44M a year earlier. Over the last 5 years it ranged from $87.20M to $533.51M, with a median of $170.42M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $412.91M | +37.7% |
| 2025 | Dec 31, 2025 | $299.79M | +100.3% |
| 2024 | Dec 31, 2024 | $149.66M | -27.3% |
| 2023 | Dec 29, 2023 | $205.86M | +6.7% |
| 2022 | Dec 30, 2022 | $192.93M | +55.3% |
| 2021 | Dec 31, 2021 | $124.22M | -69.5% |
| 2020 | Dec 31, 2020 | $407.54M | +19.6% |
| 2019 | Dec 31, 2019 | $340.76M | -56.1% |
| 2018 | Dec 31, 2018 | $775.85M | -79.0% |
| 2017 | Dec 29, 2017 | $3.70B | +270.3% |
| 2016 | Dec 30, 2016 | $997.84M | -60.7% |
| 2015 | Dec 31, 2015 | $2.54B | -55.4% |
| 2014 | Dec 31, 2014 | $5.70B | +91.9% |
| 2013 | Dec 31, 2013 | $2.97B | +690.5% |
| 2012 | Dec 31, 2012 | $375.75M | – |
See a number that looks wrong?